CLOS
SGYP

Compagnie Lombard Odier SCmA’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,100
Closed -$6K – 886
2016
Q3 		$6K Buy
+1,100
New +$5.15K ﹤0.01% 867

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Compagnie Lombard Odier SCmA's SGYP Position: Q4 2016 in Review

Compagnie Lombard Odier SCmA sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2016, closing a stake of 1,100 shares — an estimated $6K sold.

Compagnie Lombard Odier SCmA first reported a position in SGYP in Q3 2016 and held it in 1 quarter. The position peaked at $6K in Q3 2016. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • Compagnie Lombard Odier SCmA reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,100 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $6K.
  • Compagnie Lombard Odier SCmA first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2016 and held it in 1 quarter.
  • Compagnie Lombard Odier SCmA's Synergy Pharmaceuticals, Inc Common Stock position peaked at $6K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2016, filed 14 Feb 2017.